Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias

Authors

Fabio Stagno Department of Biomedical Sciences, Section of Hematology, University of Catania, Italy; *These authors contributed equally to this work
Paolo Vigneri Section of General Pathology, University of Catania, Italy; Medical Oncology Unit, Vittorio Emanuele University Hospital, Catania, Italy; *These authors contributed equally to this work
Vittorio Del Fabro Department of Biomedical Sciences, Section of Hematology, University of Catania, Italy
Stefania Stella Section of General Pathology, University of Catania, Italy
Nunzio Restuccia Medical Oncology Unit, Vittorio Emanuele University Hospital, Catania, Italy
Cesarina Giallongo Department of Biomedical Sciences, Section of Hematology, University of Catania, Italy
Michele Massimino Section of General Pathology, University of Catania, Italy
Salvatore Berretta Department of Biomedical Sciences, Section of Hematology, University of Catania, Italy
Maria Stella Pennisi Section of General Pathology, University of Catania, Italy
Daniele Tibullo Department of Biomedical Sciences, Section of Hematology, University of Catania, Italy
Elena Tirrò Section of General Pathology, University of Catania, Italy
Calogero Buscarino Medical Oncology Unit, Vittorio Emanuele University Hospital, Catania, Italy
Angelo Messina Section of General Pathology, University of Catania, Italy
Francesco Di Raimondo Department of Biomedical Sciences, Section of Hematology, University of Catania, Italy

No abstract available

Download data is not yet available.